Canary Medical

The Canary Canturio tibial extension (te) provides detailed patient activity data during recovery from total knee arthroplasty.

Download the Canary Medical app

The Canary Canturio tibial extension (te) generates post-surgical recovery data for patients with the Persona IQ Smart Knee.

Reimbursement and payment pathways are the biggest barriers to market entry for new technologies, according to Bill Hunter, M.D., CEO of Canary Medical.

Enabling technology is ushering in a new era in orthopedics and challenging the status quo.

Bill Hunter, M.D., CEO of Canary Medical, agrees that the real impact of emerging technologies will be felt by pooling the clinical data they provide.

Canary Medical recently launched Canary Quantile Recovery Curves, an analytic module that collects data from all patients who received the Persona IQ implant.

BioScience Managers invested AUS$10 million in a joint venture with Canary Medical.

Leadership Team Canary Leadership Team Canary Board Members Khaled El Emam, Ph.D. Brenda Eprile Karimah Es Sabar Jim Karkanias Dr. Isaac Kohane, M.D., Ph.D. Deneen Vojta, M.D. Khaled El Emam, Ph.D. Dr. Khaled El Emam brings over 30 years of experience. Khaled is experienced in statistical de-identification and re-identification risk measurement. He is qualified to […]

Canary Medical develops implantable medical devices to improve healthcare outcomes.

Canary Medical maintains high ethical, regulatory, and professional standards in its mission to improve patient lives through medical data.

Canary Medical provides patient and clinician support by phone and inquiry form.

Canary Medical operates in the United States and Canada, with offices in Carlsbad and Vancouver.

Canary Medical is a medical data company seeking to improve healthcare outcomes “smart” implantable medical devices.

Canary Medical’s smart implantable devices (SIDs) in primary total knee arthroplasty (TKA) reduce emergency department visits, hospital admissions, and 90-day healthcare costs. The study shows fewer unplanned care events and lower per-patient costs, suggesting implant-derived recovery data can improve postoperative coordination, align patient expectations, and decrease acute care burdens after TKA.

Dec 2025Canary MedicalNews article

Canary Medical licenses sensor technology from VTT to advance its cardiovascular program. The agreement enables Canary to integrate implantable sensor tech into its data and analytics ecosystem for heart-related applications. VTT, a Finnish research and innovation company, provides the underlying sensor technology for development.

Dec 2025Canary MedicalNews article

Canary Medical receives FDA *Breakthrough Device* designation for its **Smart Spine Lumbar Cartridge**, accelerating its path to market. This marks the company’s fourth FDA Breakthrough Designation under the program, following prior designations for other products. The designation targets innovative medical devices intended to address unmet clinical needs.

May 2024Canary MedicalNews article

Canary Medical secures the **2024 MedTech Breakthrough Award**, recognizing its innovation in medical technology. The company previously advanced as a **2023 finalist for the Best of Sensors Awards** in the medtech category, as reported by *Sensors Converge*. The award highlights Canary’s contributions to sensor-based healthcare solutions.

May 2024Canary MedicalNews article